The Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD) is a multifaceted open-data resource that is designed to identify cellular and molecular pathologies that underlie Alzheimer’s disease. Integrating neuropathology, single-cell and spatial genomics, and longitudinal clinical metadata, SEA-AD is...
A growing body of evidence suggests that dysbiosis of the human gut microbiota is associated with neurodegenerative diseases like Alzheimer’s disease (AD) via neuroinflammatory processes across the microbiota-gut-brain axis. The gut microbiota affects b
including diabetes, cardiovascular diseases, and Alzheimer’s disease (AD), have been widely described. Objective: This systematic review aimed to gather the current understanding of the pathophysiological mechanisms linking periodontitis to AD. Methods: An electronic systematic search of the PubMed/MEDLIN...
Abstract:Alzheimer's disease (AD) is a complex, heterogeneous, and progressive neurodegenerative dementia. Although the majority of AD research has primarily focused on disease-associated alterations of the cortex and hippocampus in the cerebrum, emerging evidence has highlighted the cerebellum’s involvem...
Interested in an introduction to peer reviewing articles for Alzheimer's Research & Therapy? Find out moreabout our ECR Peer Reviewer Panel! Aims and scope Alzheimer's Research & Therapyis the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, ...
The global impact of Alzheimer’s disease (AD) continues to increase, and focused efforts are needed to address this immense public health challenge. National leaders have set a goal to prevent or effectively treat AD by 2025. In this paper, we discuss the path to 2025, and what is feasibl...
Alzheimer’s is a top cause of death in the U.S. Here are places it’s hit particularly hard.
The JPAD Journal of Prevention of Alzheimer’Diseasewill publish reviews, original research articles and short reports to improve our knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and ...
Forecast Period 2023 –2030 Market Size (Base Year) USD 5.10 Billion Market Size (Forecast Year) USD 9.73 Billion CAGR 8.40 % Major Markets Players Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock Global Alzheimer’s Disease Market, By Type (Early-onset Alzheimer's, Late-onset...
Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and ne